Sublease Termination AgreementSublease Termination Agreement • January 22nd, 2020 • Regen BioPharma Inc • Pharmaceutical preparations
Contract Type FiledJanuary 22nd, 2020 Company IndustryEffective January 22, 2020 at 1 pm Pacific Standard Time, BST Partners Inc. (Sublessor / Sublandlord) hereby terminates the subleases with Sublessees / Subtenants: Regen BioPharma Inc. (along with its wholly owned subsidiary KCL Therapeutics Inc.) and Zander Therapeutics Inc.